The latest closing stock price for Cyclerion Therapeutics as of April 10, 2025 is 2.56.
An investor who bought $1,000 worth of Cyclerion Therapeutics stock at the IPO in 2019 would have $-990 today, roughly -1 times their original investment - a -53.40% compound annual growth rate over 6 years.
The all-time high Cyclerion Therapeutics stock closing price was 457.00 on April 01, 2019.
The Cyclerion Therapeutics 52-week high stock price is 9.47, which is 269.9% above the current share price.
The Cyclerion Therapeutics 52-week low stock price is 1.27, which is 50.4% below the current share price.
The average Cyclerion Therapeutics stock price for the last 52 weeks is 2.86.
An investor who bought $1,000 worth of Cyclerion Therapeutics stock at the IPO in 2019 would have $-990 today, roughly -1 times their original investment - a -53.40% compound annual growth rate over 6 years.
The all-time high Cyclerion Therapeutics stock closing price was 457.00 on April 01, 2019.
The Cyclerion Therapeutics 52-week high stock price is 9.47, which is 269.9% above the current share price.
The Cyclerion Therapeutics 52-week low stock price is 1.27, which is 50.4% below the current share price.
The average Cyclerion Therapeutics stock price for the last 52 weeks is 2.86.